- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
EGATEN for Treatment of Fascioliasis
Anthelmintic tablet for patients 6 years of age and older.
EGATEN™ (triclabendazole, Novartis)
Indications: treatment of fascioliasis in patients six years of age or older
Dosage:
- 2 doses of 10 mg/kg given 12 hours apart in patients age 6 years of age or older
- Take orally with food
- Can be swallowed whole, divided in half and taken with water, or crushed and administered with applesauce
- âRound dose upwards if unable to adjust exactly
Contraindications: known hypersensitivity to triclabendazole, other benzimidazole derivatives or any of the excipients in EGATEN
Stress Ulcer Prophylaxis May Not Prevent Gastrointestinal Bleeding in Neonates
December 4th 2023According to a poster presented at ASHP Midyear 2023, stress ulcer prophylaxis (SUP) did not increase adverse effects, suggesting limited preventive benefits for gastrointestinal bleeding (GIB) in neonates.
Navigating a Complicated Pediatric COVID-19 Case With Immunomodulatory Therapies
November 6th 2023A poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition, featured a complex pediatric case involving SARS-CoV-2, bacterial coinfection, multiorgan failure, thrombotic microangiopathy, and systemic hyperinflammation.
